Sofinnova

Investor type

VC

Founded

1972

AUM

$1 500 M

Location

Paris, Île-de-France, France

Investment Ticket

$5-10 m

Investment Stage

Seed Series B

Region of investment

North America South America Europe Asia
Investor profile last updated: 21 August, 2026

Profile

Sofinnova Partners is a leading European venture capital firm specialized in Life Sciences. Based in Paris, France, the firm brings together 12 highly experienced investment professionals from all over Europe, the US and China. The firm focuses on paradigm shifting technologies alongside visionary entrepreneurs. Sofinnova Partners seeks to invest as a founding and lead investor in start-ups and corporate spin-offs, and has backed nearly 500 companies over more than 40 years, creating market leaders around the globe.

Industry

Biotechnology Healthcare Services Medical Devices Pharmaceuticals Financial Services Fintech Food and Beverage Foodtech Gaming Marketing and Advertising Real Estate Robotics Security Software Telecommunications MedTech Energy HealthTech

Contacts

Name
Title
Email
avatar
Alain Azan Founding Partner
Founding Partner
a•••@•••
avatar
Goro Takeda Venture Partner
Venture Partner
g•••@•••
Upgrade to see contacts
avatar
4JXoaZj3tfRHsqMm 4JXoaZj3tfRHsqMm
4JXoaZj3tfRHsqMm
avatar
4JXoaZj3tfRHsqMm 4JXoaZj3tfRHsqMm
4JXoaZj3tfRHsqMm
avatar
4JXoaZj3tfRHsqMm 4JXoaZj3tfRHsqMm
4JXoaZj3tfRHsqMm
Investment-team contacts for Sofinnova — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Sofinnova

Sofinnova is a venture capital firm. It backs companies at Seed and Series B, writing tickets of $5-10 m.
Sofinnova is located in Paris, Île-de-France, France.
Sofinnova was founded in 1972.
Sofinnova invests in companies and startups in Biotechnology, Healthcare Services, Medical Devices, Pharmaceuticals, Financial Services, Fintech, Food and Beverage, Foodtech, Gaming, Marketing and Advertising, Real Estate, Robotics, Security, Software, Telecommunications, MedTech, Energy, HealthTech.
Sofinnova invests in companies and startups in North America, South America, Europe, Asia.
Sofinnova invests in companies and startups at Seed, Series B.
Sofinnova usually invests $5-10 m on average.
Sofinnova has around $1 500m assets under management.
Sofinnova can be reached through its website sofinnova.fr, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Sofinnova — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Sofinnova directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.